Research

(Part 2) Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

January 19, 2023
|
The EO Team

Despite conflicting evidence, for many patients with chronic pain, the risk of using opioids may be greater than the benefits, especially over long periods of time. It is important that patients wishing to understand the potential benefits and risks of using cannabis in addition to opioids discuss this with their health care provider prior to use.

We recently discussed the use of opioids for chronic pain, and highlighted the potential use of cannabis as an option to reduce opioid use and side effects. In the second part of this series we look at more evidence supporting cannabis use.

Evidence suggests that combining cannabis with opioids in treatment for pain may lead to a reduction in the dose of opioids or replace opioids altogether (Reiman et al., 2017;  Lucus & Walsh, 2017; Nielsen et al., 2022; MacCallum et al., 2021). A 2017 study found that 97% of medical cannabis patients agreed that by consuming cannabis, they could decrease the amount of opiates consumed (Reiman et al. 2017). Another study found that there was a 64% reduction in opioid use among cannabis users, which also led to decreased opioid-related side effects (e.g., nausea) and improved quality of life (Manzanares et al., 2006; Boehnke et al. 2016; Giorgi et al., 2020). Other symptoms such as anxiety, insomnia, and depression commonly experienced with chronic pain also improved.

It is important to acknowledge that there is some conflicting evidence showing cannabis did not help reduce pain or opioid doses. This highlights a need for more research. Despite this conflicting evidence, for many patients with chronic pain, the risk of using opioids may be greater than the benefits, especially over long periods of time. In this case, cannabis may be a useful addition. It is important that patients wishing to understand the potential benefits and risks of using cannabis in addition to opioids discuss this with their health care provider prior to use.

Stay tuned for an overview of the key concepts surrounding cannabis as a substitute for opioids in the third-part of this blog series.

References:

Boehnke KF, Litinas E, Clauw DJ. Medical cannabis use is associated with decreased opiate medication use in a retrospective cross-sectional survey of patients with chronic pain. J Pain. 2016;17(6):739–44.

Giorgi V, Bongiovanni S, Atzeni F, Marotto D, Salaffi F, Sarzi-Puttini P. Adding medical cannabis to stan- dard analgesic treatment for fibromyalgia: a prospective observational study. Clin Exp Rheumatol. 2020;38(123):S53–9.

Lucas P, Walsh Z. Medical cannabis access, use, and substitution for prescription opioids and other substances: a survey of authorized medical cannabis patients. Int J Drug Policy. 2017;42:30–5.

Manzanares J, Julian MD, Carrascosa A. Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol. 2006;4(3):239–57.

Narouze SN, MacCallum CA. eds. Cannabinoids and Pain. Springer; 2021 Chapter 27; Cannabinoids as a Substitute for Opioids: Basic Science and Clinical Evidence

Nielsen, Suzanne, et al. "Opioid-sparing effect of cannabinoids for analgesia: an updated systematic review and meta-analysis of preclinical and clinical studies." Neuropsychopharmacology 47.7 (2022): 1315-1330.

Reiman A, Welty M, Solomon P. Cannabis as a substitute for opioid-based pain medication: patient self-report. Cannabis Cannabinoid Res. 2017;2(1):160–6.

Dr. Caroline MacCallum is a specialist in internal medicine with expertise in complex pain and cannabinoid medicine. In addition to serving as an advisor to EO Care, she is a clinical instructor in the Department of Medicine; Adjunct Professor in the Faculty of Pharmaceutical Sciences program; and associate member of the Dept. of Palliative Care at the University of British Columbia. An avid researcher, Dr. MacCallum is primary author of Primary Considerations for Medical Cannabis Administration and Dosing, and assistant for Cannabinoids and Pain.

Here's where you can find Dr. Caroline MacCallum online:

- Instagram: @drcarolinemaccallum

- Twitter: @camaccallum

- Facebook: Dr. Caroline MacCallum

- LinkedIn: Dr. Caroline MacCallum, MD

- Website: https://drcarolinemaccallum.com/

<-  Back to blog
More
Research
Research

Cannabis and Cancer

Navigating a cancer diagnosis is one of the most difficult life challenges a person can face. Two-time cancer survivor and EO spokesperson Ethan Zohn says, “cancer is a disease that touches every part of you as a human being: mental, physical, social, spiritual. You’re always just looking for ways to make yourself feel better.”

Read More
Read More
Research

Gabapentin and Thc

Gabapentin and cannabis are two substances frequently used to help manage pain and a range of other health conditions. While gabapentin is primarily used to help treat nerve pain, seizures and shingles-related discomfort, cannabis is well known for its analgesic, anti-inflammatory and relaxation-inducing effects.

Read More
Read More
Research

THC Inhaler vs Vape

A growing body of research illustrates the untapped potential of cannabis for a range of medical uses, like helping to manage pain, stress, sleep and appetite. However, studies also indicate that alternative methods of intake are necessary to create consistent, repeatable effects and to reduce the risks associated with smoking cannabis. According to a scientific review by the Institute of Medicine, “the future of cannabinoid drugs lies not in smoked marijuana but in chemically defined drugs that act on the cannabinoid systems that are a natural component of human physiology.”

Read More
Read More